Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 81551-81600 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05700929
Evaluation of a Communication Skills Training for Nurses
NA
Active, not recruiting
207 participants
Started: Nov 14, 2022 · Completed: Nov 30, 2024
1 condition
1 sponsor
1 location
NCT03886675
Intervention With Cerebral Embolic Protection in TEVAR: Gaseous Protection
NA
Recruiting
120 participants
Started: Nov 14, 2022 · Completed: Oct 31, 2024
4 conditions
9 sponsors
1 location
NCT05458713
The Effect of Laser Acupuncture in Different Meridians on the Autonomic Nervous System and Its Brain Mechanisms
NA
Active, not recruiting
80 participants
Started: Nov 13, 2022 · Completed: Dec 31, 2024
4 conditions
2 sponsors
1 location
NCT05634681
Plan of the Day Radiotherapy
NA
Recruiting
190 participants
Started: Nov 13, 2022 · Completed: Dec 31, 2032
1 condition
1 sponsor
1 location
NCT04496895
The Evaluation of Orange Peel Fermentation on Body Fat Lowering Efficacy in Adults
NA
Recruiting
124 participants
Started: Nov 12, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT06300684
Exploring CBTi's Dual Effect on Sleep, Diet, & Chrononutrition
NA
Recruiting
40 participants
Started: Nov 11, 2022 · Completed: Jan 31, 2025
1 condition
1 sponsor
2 locations
NCT04925492
PET Imaging of Vaso-Occlusive Crisis (VOC) in SCD
PHASE1
Recruiting
20 participants
Started: Nov 11, 2022 · Completed: Dec 31, 2027
1 condition
2 sponsors
1 location
NCT05429463
Neoadjuvant Therapy of Sintilimab Combined With Chemotherapy for Resectable Squamous Cell NSCLC(neoSCORE Ⅱ)
PHASE3
Recruiting
250 participants
Started: Nov 11, 2022 · Completed: Nov 11, 2029
1 condition
1 sponsor
1 location
NCT05394844
Diabetes Education With Real-time Continuous Glucose Monitoring
NA
Active, not recruiting
120 participants
Started: Nov 11, 2022 · Completed: Nov 30, 2024
1 condition
5 sponsors
2 locations
NCT05646550
Antibody CC-1 in Men With Biochemical Recurrence of Prostate Cancer
PHASE1
Recruiting
56 participants
Started: Nov 11, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05474027
Reducing Hypotensive Anesthesia Use with TXA During Orthognathic Surgery
PHASE4
Enrolling by invitation
50 participants
Started: Nov 11, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT04768920
Examining Feasibility and Acceptability of Telemedicine for Substance Use Disorder (SUD)
NA
Active, not recruiting
50 participants
Started: Nov 11, 2022 · Completed: Feb 28, 2026
3 conditions
1 sponsor
1 location
NCT05839587
Transabdominal Preperitoneal Inguinal Hernia Repair
NA
Active, not recruiting
150 participants
Started: Nov 11, 2022 · Completed: May 31, 2025
2 conditions
1 sponsor
1 location
NCT05634902
Implementation of Evidence-Based Practice for Dizziness
NA
Active, not recruiting
80,000 participants
Started: Nov 11, 2022 · Completed: Mar 31, 2025
4 conditions
4 sponsors
1 location
NCT05628857
A Study of RC108-ADC in Subjects With Advanced Digestive System Malignant Tumor
PHASE2
Active, not recruiting
240 participants
Started: Nov 11, 2022 · Completed: Oct 15, 2025
1 condition
1 sponsor
1 location
NCT05928936
Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD
PHASE2
Recruiting
156 participants
Started: Nov 11, 2022 · Completed: Jun 1, 2028
1 condition
2 sponsors
2 locations
NCT05599724
PMA-FERTITHEQUE Biocollection
N/A
Recruiting
250 participants
Started: Nov 11, 2022 · Completed: Aug 15, 2028
2 conditions
1 sponsor
1 location
NCT07139171
Study on the Role and Mechanism of Plasma Exosome microRNAs in Cognitive Impairment in First-episode Schizophrenia
N/A
Recruiting
300 participants
Started: Nov 11, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05408221
the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib in Hepatocellular Carcinoma
PHASE2/PHASE3
Recruiting
576 participants
Started: Nov 11, 2022 · Completed: Aug 1, 2026
1 condition
1 sponsor
5 locations
NCT06218784
A MAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers and PHN Patients.
PHASE1
Recruiting
64 participants
Started: Nov 11, 2022 · Completed: Jul 29, 2024
7 conditions
1 sponsor
1 location
NCT06196606
Effect of Botulinum Toxin Injection Into Upper Esophageal Sphincter in Patients With Medullary Infarction
NA
Recruiting
20 participants
Started: Nov 11, 2022 · Completed: Dec 12, 2024
3 conditions
1 sponsor
1 location
NCT05476770
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
PHASE1
Recruiting
54 participants
Started: Nov 11, 2022 · Completed: Nov 11, 2027
11 conditions
1 sponsor
31 locations
NCT05654883
New York City Observational Study of Mpox Immunity
N/A
Enrolling by invitation
174 participants
Started: Nov 11, 2022 · Completed: Jun 30, 2026
3 conditions
1 sponsor
1 location
NCT05625490
Myocardial Perfusion Imaging Galmydar Rest/Stress
EARLY_PHASE1
Recruiting
30 participants
Started: Nov 11, 2022 · Completed: Dec 1, 2025
1 condition
3 sponsors
1 location
NCT05620693
Study of NY-ESO-1 TCR-T in Advanced Soft Tissue Sarcoma
NA
Recruiting
20 participants
Started: Nov 11, 2022 · Completed: Dec 1, 2028
1 condition
1 sponsor
1 location
NCT05498428
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
PHASE2
Recruiting
520 participants
Started: Nov 11, 2022 · Completed: Aug 17, 2027
1 condition
1 sponsor
110 locations
NCT05384587
Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia
PHASE2
Active, not recruiting
34 participants
Started: Nov 11, 2022 · Completed: Oct 17, 2027
1 condition
1 sponsor
80 locations
NCT05734430
Genetics of Appendix Cancer Study
N/A
Recruiting
700 participants
Started: Nov 11, 2022 · Completed: Nov 30, 2034
15 conditions
1 sponsor
1 location
NCT05590702
French Observational Study of Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in Real-World Settings
N/A
Recruiting
1,000 participants
Started: Nov 11, 2022 · Completed: Dec 1, 2032
1 condition
5 sponsors
57 locations
NCT05520086
Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.
PHASE1/PHASE2
Active, not recruiting
20 participants
Started: Nov 11, 2022 · Completed: Nov 11, 2024
4 conditions
2 sponsors
8 locations
NCT05639907
Miniscrew Stability and Peri-implant Inflammation When Precoated K21 vs Ethanol Control
NA
Recruiting
30 participants
Started: Nov 11, 2022 · Completed: Jun 30, 2028
1 condition
1 sponsor
1 location
NCT05372679
REDUCED 1 - Renal Denervation Using Ultrasonic Catheter EmitteD Energy Study /
NA
Active, not recruiting
25 participants
Started: Nov 11, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
9 locations
NCT05527470
Induction Chemotherapy Followed by IMRT or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
PHASE3
Recruiting
440 participants
Started: Nov 11, 2022 · Completed: Nov 11, 2027
1 condition
6 sponsors
2 locations
NCT05521802
A Study of C-CAR088 in Patients With Relapsed or Refractory Multiple Myeloma
PHASE1/PHASE2
Recruiting
92 participants
Started: Nov 11, 2022 · Completed: Jul 31, 2037
1 condition
1 sponsor
1 location
NCT05368662
Quality of Life and Quality of Sleep Studies in Children with Home Care Ventilation in the West of France
NA
Recruiting
160 participants
Started: Nov 11, 2022 · Completed: Sep 24, 2026
2 conditions
1 sponsor
1 location
NCT05606068
A Novel Limb Cryocompression System for Prevention of Chemotherapy Induced Peripheral Neuropathy - Expansion Study
NA
Recruiting
80 participants
Started: Nov 11, 2022 · Completed: Nov 30, 2026
1 condition
4 sponsors
2 locations
NCT04319276
Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma
PHASE1
Active, not recruiting
26 participants
Started: Nov 11, 2022 · Completed: Oct 10, 2025
1 condition
1 sponsor
1 location
NCT05493475
Evaluation of a Novel Intervention to Prevent Polysubstance Overdoses Involving Illicit Stimulants
NA
Active, not recruiting
1,750 participants
Started: Nov 10, 2022 · Completed: Sep 30, 2025
3 conditions
1 sponsor
1 location
NCT05612607
Switched Memory B-cells as a Marker for Humoral Immune System Recovery in Patients With Secondary Antibody Deficiency Due to Hematological Malignancies
PHASE4
Not yet recruiting
100 participants
Started: Nov 10, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
0 locations
NCT05524311
Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis (MYOCIT)
PHASE2
Recruiting
16 participants
Started: Nov 10, 2022 · Completed: Sep 30, 2026
1 condition
1 sponsor
13 locations
NCT05513846
Brain Age and Sleep Architecture in Meditators
N/A
Active, not recruiting
100 participants
Started: Nov 10, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05270733
Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics
PHASE4
Recruiting
56 participants
Started: Nov 10, 2022 · Completed: Dec 31, 2026
1 condition
3 sponsors
1 location
NCT05282953
A Phase I/II Dose-escalating Study of the Safety, Tolerability and Efficacy of KIO-301 Administered Intravitreally to Patients With Retinitis Pigmentosa and Choroideremia (ABACUS)
PHASE1/PHASE2
Recruiting
12 participants
Started: Nov 10, 2022 · Completed: Jul 31, 2026
2 conditions
1 sponsor
2 locations
NCT06801262
TreaT-Assay: the New Frontier for the Diagnosis of Acute Rejection in Kidney Transplantation
N/A
Recruiting
150 participants
Started: Nov 10, 2022 · Completed: May 1, 2026
3 conditions
1 sponsor
1 location
NCT05173844
Digital Sleep Therapy for Older Adults with Cognitive Impairment
NA
Active, not recruiting
128 participants
Started: Nov 10, 2022 · Completed: Apr 15, 2025
2 conditions
1 sponsor
1 location
NCT05669495
ANNE Vital Sign System Remote Sleep Assessment
N/A
Recruiting
750 participants
Started: Nov 10, 2022 · Completed: Oct 31, 2025
4 conditions
2 sponsors
1 location
NCT05306834
Stopping Cognitive Decline and Dementia by Fighting Covert Cerebral Small Vessel Disease
NA
Recruiting
400 participants
Started: Nov 10, 2022 · Completed: Nov 30, 2027
3 conditions
1 sponsor
2 locations
NCT05635227
Dexamethasone, Olanzapine, Hemodynamics, and Ventilation in Cardiac Surgery
NA
Recruiting
1,200 participants
Started: Nov 10, 2022 · Completed: Feb 29, 2028
2 conditions
1 sponsor
1 location
NCT05603741
Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers
PHASE4
Active, not recruiting
155 participants
Started: Nov 10, 2022 · Completed: Jun 30, 2027
2 conditions
2 sponsors
1 location
NCT06435403
SARS-CoV-2 Specific Antibody Responses and Impact for COVID-19 Disease in Ethiopia
N/A
Recruiting
1,000 participants
Started: Nov 10, 2022 · Completed: Feb 28, 2025
3 conditions
3 sponsors
2 locations
Previous
1
More pages
1629
1630
1631
1632
1633
1634
1635
More pages
2369
Next